Since adaptive immunity is essential for mediating tumor rejection and for controlling tumor growth in our model39, the reduced percentage of activated effector CD4+ and CD8+ T cells observed in tumors of Clec4a2−/− mice likely accounts for the increased tumor growth observed in these mice. The gene discussed is CD8A; the disease is neoplasm.